<DOC>
	<DOCNO>NCT02534636</DOCNO>
	<brief_summary>The purpose study establish BMS-986165 safe effective treat autoimmune disease . BMS-986165 show promise preclinical study inhibit autoimmune condition . This study first time drug give human , conduct entirely healthy subject . It run 4 Parts . Part A investigate single oral dos drug . Part B investigate give drug daily 14 day . Part C investigate daily dose 14 day healthy volunteer Japanese decent . Part D investigate whether food , stomach acidity give drug capsule make difference safety potential use drug .</brief_summary>
	<brief_title>Safety Study BMS-986165 Healthy Subjects Treat Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy Male Female participant 18 50 year age ( Parts AD ) Participants recent infection Participants low blood pressure increase heart rate Participants chronic health relate problem Participants active cancer within last 5 year Participants major medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>